Skip to main content
ELDN logo

ELDN

Eledon Pharmaceuticals, Inc.

$3.85

6.66%

Trade Ideas Performance

Latest Closed Trade Idea

$3.85

6.66%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

21

Social

31

About

Events of Eledon Pharmaceuticals, Inc. (ELDN)

Over the past six months, Eledon Pharmaceuticals' stock has experienced significant volatility. In November 2025, the stock plunged dramatically following mixed results from its Phase 2 BESTOW clinical trial. In December 2025, news reports indicated biotech momentum carrying after-hours trading gains. In March 2026, Eledon reported its fourth quarter and full year 2025 operating and financial results, highlighting progress in advancing tegoprubart and the FDA granted Orphan Drug designation for liver transplantation. In early 2026, the stock price has risen significantly, driven by positive news regarding tegoprubart's early success in human clinical trials. In April 2026, BlackRock reported a stake in Eledon and Eledon proposed a share authorization increase. In May 2026, the company is estimated to announce its Q1 2026 earnings.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Eledon Pharmaceuticals, Inc. (ELDN) Live Stock Price, Chart & Financial News | Edge Hound